Does RIBOCICLIB Cause Metastases to liver? 967 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 967 reports of Metastases to liver have been filed in association with RIBOCICLIB (KISQALI). This represents 3.5% of all adverse event reports for RIBOCICLIB.
967
Reports of Metastases to liver with RIBOCICLIB
3.5%
of all RIBOCICLIB reports
210
Deaths
236
Hospitalizations
How Dangerous Is Metastases to liver From RIBOCICLIB?
Of the 967 reports, 210 (21.7%) resulted in death, 236 (24.4%) required hospitalization, and 51 (5.3%) were considered life-threatening.
Is Metastases to liver Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 967 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Metastases to liver?
LETROZOLE (1,295)
FULVESTRANT (1,241)
CAPECITABINE (1,061)
EVEROLIMUS (1,020)
PACLITAXEL (885)
OCTREOTIDE (774)
BEVACIZUMAB (707)
FLUOROURACIL (630)
TAMOXIFEN (595)
OXALIPLATIN (569)
Which RIBOCICLIB Alternatives Have Lower Metastases to liver Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN